Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B (PREVENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03055611
Recruitment Status : Recruiting
First Posted : February 16, 2017
Last Update Posted : April 11, 2019
Sponsor:
Information provided by (Responsible Party):
Swedish Orphan Biovitrum

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021